Day One Biopharmaceuticals, Inc. (DAWN)
Free
No email, no account, no signup.
Pulling latest news for Day One Biopharmaceuticals, Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Targeted cancer therapies
Market Cap
$2.5B
We're already tracking Day One Biopharmaceuticals, Inc. — here are the latest events we've registered
Recent News
- On April 23, 2026, Day One Biopharmaceuticals completed its merger with Servier in an all-cash transaction valued at approximately $2.5 billion. Following the acquisition, the company filed a Form 15-12G to delist its common stock from the Nasdaq on May 4, 2026. Shareholders received $21.50 per share as part of the deal.
Want to know how this news affects Day One Biopharmaceuticals, Inc.? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Day One Biopharmaceuticals, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.